Hitting the BBB
In 2014, the Tufts Center for the Study of Drug Development reported that drugs developed between 1999 and 2013 that were designed to target CNS diseases took more than one year longer (12.8 months, 18 percent longer) to develop than non-CNS drugs. This analysis included 42 CNS and 345 non-CNS therapeutic compounds approved by the […]